Nan Fung Life Sciences
Wendy Ardrey is Senior Vice President, Head of Investor Relations for Pivotal Life Sciences. She was a Senior Director – Private Markets Business Development at Aberdeen Standard Investments, where she specialized in developing private investment strategies for family offices and endowments and foundations. Wendy has more than 20 years of investment experience, including 13 years in private capital. Wendy joined FLAG Capital Management in 2008, which was subsequently acquired by Aberdeen Asset Management in September 2015. Prior to joining FLAG in 2008, Wendy was a consultant at DKR Capital Inc., a multi-strategy hedge fund, focusing on new business and client service. Prior to DKR, Wendy held positions at Renaissance Capital, an IPO research firm, First Boston, focusing on fixed income capital markets, and PaineWebber, where she specialized in corporate finance. Wendy holds a JD / MBA from University of Santa Clara and a BA from Stanford University.
This person is not in any offices
Nan Fung Life Sciences
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group’s strong capital base and long-term commitment to the area, the company is aimed to become the ideal partner for scientists, entrepreneurs, corporations, and investors in the life science space. Through direct investments via Pivotal bioVenture Partners funds (both in US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices, and diagnostics) and across different development stages, Nan Fung Life Sciences has a significant presence in both US and Greater China.